KCM
GOSS icon

Kynam Capital Management’s Gossamer Bio GOSS Stock Holding History

Kynam Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,125
Closed -$208K – 26
2023
Q3 		$208K Buy
+3,125
New +$288K 0.03% 27
2023
Q2 		– Sell
-18,786
Closed -$1.89M – 29
2023
Q1 		$1.89M Sell
18,786
-3,358
-15% -$514K 0.24% 26
2022
Q4 		$3.84M Buy
22,144
+17,315
+359% +$11.4M 0.59% 22
2022
Q3 		$4.63M Sell
4,829
-24,552
-84% -$24.4M 0.98% 23
2022
Q2 		$19.7M Buy
29,381
+6,472
+28% +$4.01M 5.02% 7
2022
Q1 		$15.9M Buy
22,909
+10,198
+80% +$7.87M 5.16% 6
2021
Q4 		$11.5M Buy
+12,711
New +$12.1M 6.15% 4

Other funds holding GOSS

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Platinum Investment Management
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Eversept Partners
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Kynam Capital Management's GOSS Position: Q4 2023 in Review

Kynam Capital Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 3,125 shares — an estimated $208K sold.

Kynam Capital Management first reported a position in GOSS in Q4 2021 and held it in 7 quarters. The position peaked at $19.7M in Q2 2022. 96 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Kynam Capital Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Kynam Capital Management sold 3,125 Gossamer Bio shares in Q4 2023, an estimated $208K.
  • Kynam Capital Management first reported a position in Gossamer Bio in Q4 2021 and held it in 7 quarters.
  • Kynam Capital Management's Gossamer Bio position peaked at $19.7M in Q2 2022.
  • 96 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Kynam Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.